StonvexLoading…
StonvexStonvexStonvexCore line items from ROK's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-09-30 | Annual 2024 2024-09-30 | Annual 2023 2023-09-30 | Annual 2022 2022-09-30 |
|---|---|---|---|---|
Revenue | $8.34B | $8.26B | $9.06B | $7.76B |
Operating Income | $1.70B | $1.59B | $1.93B | $1.07B |
Net Income | $869.00M | $953.00M | $1.39B | $932.20M |
EPS (Diluted) | $7.67 | $8.28 | $11.95 | $7.97 |
Total Assets | $11.22B | $11.23B | $11.30B | $10.76B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $468.00M | $471.00M | $1.07B | $490.70M |
Free Cash Flow OCF − CapEx | $1.36B | $639.00M | $1.21B | $682.00M |
Shares Outstanding | 112.40M | 113.10M | 114.80M | 115.20M |